Skip to main content

Helicobacter pylori

  • Book
  • © 2016

Overview

  • Reviews the most recent pathogenetic, diagnostic, and therapeutic approaches in connection with Helicobacter pylori

  • Maximizes reader insight into the trends in clinical practice to address Helicobacter pylori

  • Provides comprehensive knowledge for treating Helicobacter pylori

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (16 chapters)

  1. History

  2. Pathogenesis

  3. Diagnosis

  4. Treatment

Keywords

About this book

This book provides a detailed review of the most recent pathogenetic, diagnostic and therapeutic approaches in connection with Helicobacter pylori, along with priority areas in research and trends in clinical practice to address this significant pathogen acknowledged as the causative agent in a wide range of diseases, including gastric adenocarcinoma, MALT lymphoma and immune thrombocytopenic purpura (ITP). Medical authorities worldwide now recommend a “test and treat” strategy for this bacterial infection. Eradication therapy approaches range from general mass eradication therapy to tailor-made therapy for antibiotic-resistant refractory infection. In regions with high prevalence of H. pylori infection, the infection itself would be considered a major parameter to predict the risk of gastric adenocarcinoma development. The main interest has shifted recently to the risk stratification strategy for gastric cancer development and to the wide-ranging application of its serological prevention program.

This book will benefit all gastroenterologists, hematologists, dermatologists, primary care doctors, epidemiologists, physicians who related with community hygiene, as well as basic scientists, particularly microbiologists, bacteriologists, pathologists, molecular biologists, biochemists, immunologists and oncologists.

Editors and Affiliations

  • Medical Education Center, Keio University School of Medicine, Tokyo, Japan

    Hidekazu Suzuki

  • The Royal Perth Hospital, The University of Western Australia and, Western Australia, Australia

    Robin Warren, Barry Marshall

About the editors

Dr Hidekazu Suzuki,

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

Dr Robin Warren,

A winner of the 2005 Nobel Prize winner in Physiology or Medicine

Emeritus Professor at the University of Western Australia and the Royal Perth Hospital, Australia

 Dr Barry Marshall,

A winner of the 2005 Nobel Prize winner in Physiology or Medicine

Marshall Centre for Infectious Diseases Research and Training, School of Pathology and Laboratory Medicine, The University of Western Australia, Australia

Bibliographic Information

  • Book Title: Helicobacter pylori

  • Editors: Hidekazu Suzuki, Robin Warren, Barry Marshall

  • DOI: https://doi.org/10.1007/978-4-431-55705-0

  • Publisher: Springer Tokyo

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Japan 2016

  • Hardcover ISBN: 978-4-431-55704-3Published: 26 April 2016

  • Softcover ISBN: 978-4-431-56679-3Published: 22 April 2018

  • eBook ISBN: 978-4-431-55705-0Published: 13 April 2016

  • Edition Number: 1

  • Number of Pages: X, 267

  • Number of Illustrations: 17 b/w illustrations, 26 illustrations in colour

  • Topics: Gastroenterology, Pathology, Hematology

Publish with us